Cardiovascular calcification is the calcification or hardening of the arteries and heart valves, where calcium deposits build up in the inner layer of the arteries. This condition is commonly caused by age, atherosclerosis, chronic kidney disease, diabetes or genetic predisposition. Calcification of the arteries can narrow or block the passageways, forcing the heart to work harder to pump blood. The global cardiovascular calcification market is primarily driven by the rising geriatric population and increasing prevalence of heart diseases. Other key factors include the growing demand for minimally invasive diagnostic and treatment methods and technological advancements in targeted drug delivery systems.

The cardiovascular calcification market is estimated to be valued at USD 125.2 billion in 2024 and is expected to reach USD 174.6 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.

Key Takeaways

- Key players operating in the cardiovascular calcification market are GE Healthcare, Medtronic Plc, Siemens Healthineers AG, Philips Healthcare, Arineta Ltd.

- Growing geriatric population suffering from chronic diseases like diabetes and kidney disorders is fueling the demand for early diagnosis and treatment of Cardiovascular Calcification Market

- Advancements in minimally invasive imaging technologies like CT scans and ultrasound are enabling precise detection and quantification of calcified plaques in coronary arteries and valves.

Market Trends

- Increasing R&D investments by pharmaceutical companies in developing targeted drug delivery systems for inhibiting vascular calcification without affecting normal bone mineralization. Nanoparticle-based drug carriers are gaining traction.
- Growing adoption of calcification scoring methods like Agatston score and Volume Calcification Score (VCSc) that help physicians better assess cardiovascular risk and monitor disease progression. This is propelling the demand for advanced cardiac imaging modalities.

Market Opportunities

- Untapped potential in emerging economies due to rising healthcare expenditure and growing medical tourism.
- Development of novel biomarkers for early detection of calcification and monitoring treatment response can create new revenue streams.

Impact of COVID-19 on Cardiovascular Calcification Market Growth

The outbreak of novel coronavirus has severely impacted the cardiovascular calcification market. During pre-COVID times, the market was growing steadily owing to increasing prevalence of cardiovascular disorders like coronary artery disease, hypertension etc. which leads to calcification of arteries and heart valves over time. However, the pandemic emerged as a major challenge since it directly attacks the cardiovascular system in many patients.

Resources including infrastructure and healthcare professionals had to be diverted to handle rising COVID cases. Non-essential medical procedures and routine check-ups were postponed. This hampered early detection of calcification and affected the demand for diagnostic tests in 2020. Lockdowns and fear of contracting infection prevented patients from visiting hospitals even in emergency cases. Subsequently, the treatment seeking rates for cardiovascular calcification reduced drastically.

As the pandemic situation continues, companies in this market are focusing on teleconsultation and home delivery options. Point-of-care testing devices are being developed for self-monitoring and decentralized use. Researchers are also investigating the impact of COVID-19 on calcification progression. It is expected that once normalcy returns, pent-up demand and emphasis on preventive healthcare will boost the market. However, short-term financial impact on consumers can dampen the growth trajectory.

Geographically, in terms of value, North America holds a major share of the cardiovascular calcification market currently. This is owing to the rising obesity-related health issues and growing geriatric population who are susceptible to calcification diseases in the region. Availability of advanced diagnostics and well-established healthcare infrastructure have also supported market growth.

Asia Pacific region is poised to become the fastest growing market during the forecast period. Factors such as increasing healthcare expenditure, growing awareness about cardiovascular disorders, rising disposable incomes are contributing towards the growth of the cardiovascular calcification market in emerging nations of China and India. Furthermore, expansion of private healthcare facilities and diagnostic centers indicates promising opportunities.

Explore additional details from the source - The Growing Cardiovascular Calcification Market is Trending due to Increasing CVD Cases Globally

Explore additional details from the source -
Cardiovascular Calcification Management is Estimated to Witness Moderate Growth due to Rising Prevalence of Cardiovascular Diseases

Explore additional details from the source - Cardiovascular Calcification Management is Estimated to Witness High Growth Owing to Advancement in Calcium Score Imaging

Explore additional details from the source - The Global Cardiovascular Calcification Management Market is Anticipated to Witness High Growth Owing to Rising Cardiovascular Diseases.

Author Bio:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)